v3.23.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Compensation  
Schedule of stock option activity under all of the Company's equity incentive plans

    

    

    

    

Weighted

    

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)’

Value (000’s)

Outstanding as of January 1, 2021

 

1,963,814

 

7,056,000

$

1.33

 

8.58

 

$

7,116

Granted

 

(2,415,000)

 

2,415,000

 

7.75

 

  

 

  

Exercised

(4,396)

0.91

Forfeited

 

657,189

 

(657,189)

 

1.83

 

  

 

  

Expired

10,000

(10,000)

Outstanding as of December 31, 2021

 

216,003

 

8,799,415

3.07

 

8.12

60,924

2022 Equity incentive plan

5,000,000

Granted

 

(2,272,299)

 

2,272,299

 

3.26

 

  

 

  

Exercised

 

 

(395,235)

 

1.39

 

  

 

  

Forfeited

 

582,898

 

(582,898)

 

4.31

 

  

 

  

Expired

11,666

(11,666)

2.34

Outstanding as of December 31, 2022

 

3,538,268

 

10,081,915

$

3.11

 

7.61

$

4,099

Vested and exercisable as of December 31, 2022

 

5,129,008

$

2.03

 

6.48

$

3,383

Schedule of assumptions utilized for option grants

    

Year Ended December 31, 

2022

    

2021

 

Risk-free interest rate

 

7.33

%  

1.16

%

Expected dividend yield

 

%  

%

Expected volatility

 

54.60

%  

49.74

%

Expected term (in years)

 

5.97

 

3.43

Schedule of stock-based compensation expense recognized in the Company's statements of operations

    

Year ended December 31, 

2022

    

2021

Cost of revenue, net

$

348

$

201

Research and development

 

1,058

 

386

Sales and marketing

 

235

 

167

General and Administrative

 

1,898

 

515

Total

$

3,539

$

1,269